迟发性膜迷路积水的研究现状

陈耔辰; 张玉忠; 徐勇; 高滢; 成颖; 张滟; 胡娟; 马伟军; 张青; 许珉

doi:10.13201/j.issn.1001-1781.2017.23.021

迟发性膜迷路积水的研究现状

- 1 西安交通大学第二附属医院耳鼻咽喉头颈外科(西安, 710004);
- 2 西安一四一医院耳鼻咽喉科
基金项目:
国家自然基金资助项目 (No:81541040

81670945)

陕西省国际科技合作重点项目 (No:2017KW)

西安交通大学医学院第二附属医院人才培养专项基金[No:RC (GG) 201407]

西安交通大学第二附属医院新技术新疗法重点项目 (No:2016YL-018)

详细信息

通讯作者: 张青, E-mail:zhqent@163.com

中图分类号: R764.33

收稿日期: 2017-06-15

Advance in research of delayed endolymphatic hydrops

More Information

Corresponding author: ZHANG Qing, E-mail: zhqent@163.com

Received Date: 15 June 2017

摘要

- 迟发性膜迷路积水 /
- 聋 /
- 前庭诱发肌源性电位
Abstract: Delayed endolymphatic hydrops (DEH) is a disease entity first described by Kamei and named by Schuknecht, defined as profound sensorineural deafness at early stage and after several years started to appear clinical feature of endolymphatic hydrops such as vertigo, aural fullness like Meniere's disease or fluctuating hearing loss in the contralateral ear.DEH can be classified into ipsilateral type, contralateral type and bilateral type.Although DEH has low incident rate, there are many kinds of etiology and audiology and vestibular tests.Up to now, a lot of literatures about etiology, diagnose, clinical manifestation, relevant examination and therapy of DEH were published abroad.In this review, we will make a summary of research status of DEH.
- delayed endolymphatic hydrops /
- deafness /
- vestibular evoked myogenic potential

HTML全文

参考文献(26)

[1]	KAMEI T.Delayed endolymphatic hydrops as a clinical entity[J].Int Tinnitus J, 2004, 10:137-143.
[2]	HUANG T, SLIN C C.Delayed endolymphatic hydrops:study and review of clinical implications and surgical treatment[J].Ear Nose Throat J, 2001, 80:76-78, 81-72, 84.
[3]	FUJINO K, NAITO Y, ENDO T, et al.Clinical characteristics of delayed endolymphatic hydrops:long-term results of hearing and efficacy of hyperbaric oxygenation therapy[J].Acta Otolaryngol Suppl, 2007, 557:22-25.
[4]	EGAMI N, USHIO M, YAMASOBA T, et al.Indication of the side of delayed endolymphatic hydrops by vestibular evoked myogenic potential and caloric test[J].ORL J Otorhinolaryngol Relat Spec, 2010, 72:242-246.
[5]	JERIN C, KRAUSE E, ERTL-WAGNER B, et al.Clinical features of delayed endolymphatic hydrops and intralabyrinthine schwannoma:An imaging-confirmed comparative case series[J].HNO, 2017, 65 (Suppl 1):41-45.
[6]	SUZUKI M, HANAMITSU M, KITANISHI T, et al.Autoantibodies against inner ear proteins in patients with delayed endolymphatic hydrops and unilateral juvenile deafness[J].Acta Otolaryngol, 2006, 126:117-121.
[7]	SHOJAKU H, WATANABE Y, TAKEDA N, et al.Clinical characteristics of delayed endolymphatic hydrops in Japan:A nationwide survey by the Peripheral Vestibular Disorder Research Committee of Japan[J].Acta Otolaryngol, 2010, 130:1135-1140.
[8]	ALBERNAZ P L.Unusual cases of delayed endolymphatic hydrops[J].Acta Otolaryngol, 2007, 127:355-359.
[9]	KITAHARA T, MAEKAWA C, KIZAWA K, et al.Plasma vasopressin and V2 receptor in the endolymphatic sac in patients with delayed endolymphatic hydrops[J].Otol Neurotol, 2009, 30:812-819.
[10]	POLLAK L.Audiovestibular findings in patients with delayed and idiopathic endolymphatic hydrops:a comparative study[J].Am J Otolaryngol, 2004, 25:151-156.
[11]	MIZUKOSHI K, SHOJAKU H, ASO S, et al.Meniere's disease and delayed endolymphatic hydrops in children[J].Acta Otolaryngol Suppl, 2001, 545:6-9.
[12]	EGGERMONT J J.Ups and Downs in 75 Years of Electrocochleography[J].Front Syst Neurosci, 2017, 11:2-2.
[13]	OHKI M, MATSUZAKI M, SUGASAWA K, et al.Vestibular evoked myogenic potentials in patients with contralateral delayed endolymphatic hydrops[J].Eur Arch Otorhinolaryngol, 2002, 259:24-26.
[14]	OHKI M, MATSUZAKI M, SUGASAWA K, et al.Vestibular evoked myogenic potentials in ipsilateral delayed endolymphatic hydrops[J].ORL J Otorhinolaryngol Relat Spec, 2002, 64:424-428.
[15]	LIN M, CYOUNG Y H.The use of vestibular test battery to identify the stages of delayed endolymphatic hydrops[J].Otolaryngol Head Neck Surg, 2012, 147:912-918.
[16]	MUROFUSHI T, MATSUZAKI M, TAKEGOSHIH.Glycerol affects vestibular evoked myogenic potentials in Meniere's disease[J].Auris Nasus Larynx, 2001, 28:205-208.
[17]	YOUNG Y H, HUANG T, WCHENG P W.Vestibular evoked myogenic potentials in delayed endolymphatic hydrops[J].Laryngoscope, 2002, 112:1623-1626.
[18]	中华耳鼻咽喉头颈外科杂志编辑委员会中华医学会耳鼻咽喉头颈外科学分会.梅尼埃病诊断和治疗指南 (2017)[J].中华耳鼻咽喉头颈外科杂志, 2017, 52 (3):167-172.
[19]	LIU B, LENG Y, ZHOU R, et al.Intratympanic steroids injection is effective for the treatment of drop attacks with Meniere's disease and delayed endolymphatic hydrops:A retrospective study[J].Medicine (Baltimore), 2016, 95:e5767.
[20]	FUKUSHIMA M, ITO R, MIYAGUCHI S, et al.Preceding profound deafness and co-factors promote development of endolymphatic hydrops in preliminary patients with delayed endolymphatic hydrops[J].Acta Otolaryngol, 2016, 136:1304-1308.
[21]	KASAI S, TERANISHI M, KATAYAMA N, et al.Endolymphatic space imaging in patients with delayed endolymphatic hydrops[J].Acta Otolaryngol, 2009, 129:1169-1174.
[22]	FUKUSHIMA M, OYA R, AKAZAWA H, et al.Gadolinium-enhanced inner ear magnetic resonance imaging for evaluation of delayed endolymphatic hydrops, including a bilateral case[J].Acta Otolaryngol, 2016, 136:451-455.
[23]	GU X, FANG Z M, LIU Y, et al.Diagnostic value of three-dimensional magnetic resonance imaging of inner ear after intratympanic gadolinium injection, and clinical application of magnetic resonance imaging scoring system in patients with delayed endolymphatic hydrops[J].J Laryngol Otol, 2014, 128:53-59.
[24]	NONOYAMA H, TANIGAWA T, TAMAKI T, et al.Evidence for bilateral endolymphatic hydrops in ipsilateral delayed endolymphatic hydrops:preliminary results from examination of five cases[J].Acta Otolaryngol, 2014, 134:221-226.
[25]	BAUER P W, MACDONALD C, BCOX L C.Intratympanic gentamicin therapy for vertigo in nonserviceable ears[J].Am J Otolaryngol, 2001, 22:111-115.
[26]	SHOJAKU H, WATANABE Y, MINETA H, et al.Long-term effects of the Meniett device in Japanese patients with Meniere's disease and delayed endolymphatic hydrops reported by the Middle Ear Pressure Treatment Research Group of Japan[J].Acta Otolaryngol, 2011, 131:277-283.